Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Enrollment is closed to new participants, reflecting a recruitment-status update on the study page. The record has been updated to include the latest revision tag v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T03:59:21.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    New revision v3.5.5 was added to the revision history, replacing the previous v3.5.4. This update signifies an administrative change to the page's version record rather than content changes.
    Difference
    0.1%
    Check dated 2026-06-06T22:37:05.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.3 to v3.5.4, indicating a newer release of the page's interface. This is a UI/system update rather than substantive changes to the study record or its data.
    Difference
    0.1%
    Check dated 2026-05-16T10:07:02.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov interface revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site tooling update rather than a change to the trial’s record data.
    Difference
    0.1%
    Check dated 2026-04-24T22:42:43.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:05.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The page history now shows a new revision labeled v3.5.0, while the previous revision v3.4.3 is no longer listed.
    Difference
    0.1%
    Check dated 2026-03-19T23:54:50.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.